DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
for Small Cell Lung Cancer (SCLC)
15 locations incl. Mobile
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07472517·Phase 3·Recruiting·Listed Mar 2026